ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,187.67
0.00%
Dow Jones
39,056.39
0.44%
US Dollar vs MXN
16.90962
0.02%
Brent Oil
83.625
0.08%
Bitcoin
61,207.45
0.03%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Inspira Technologies Oxy B H N Ltd (IINN)

  7. Inspira Technologies Oxy B H N Ltd (IINN) Noticias

IINN Inspira Technologies Oxy B H N Ltd

2.20
-0.01 (-0.45%)
Fuera de horario
Última actualización: 18:50:09
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Inspira Technologies Oxy B H N Ltd IINN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.01 -0.45% 2.20 18:50:09
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.20 1.91 2.20 2.09 2.21
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202408:18PRNUSInspira™ Announces Start of Production of the INSPIRA™..
25/4/202407:00PRNUSInspira™ Receives CSA Certification of Compliance to U.S...
16/4/202407:42PRNUSInspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device..
10/4/202407:24PRNUSInspira™ and Ennocure In Vitro Study Results Show 100%..
03/4/202407:30PRNUSInspira™ Announces Program to Pioneer the Applicable Use of..
01/4/202407:00PRNUSInspira™ Announces $1.65 Million Registered Direct Offering..
25/3/202408:20PRNUSInspira™ Technologies Reports Full Year 2023 Financial..
18/3/202406:00PRNUSInspira™ Announces AMAR Regulatory Submission of the..
12/3/202407:00PRNUSInspira™ Releases New Data Demonstrating Superiority of its..
08/3/202415:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/3/202415:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/3/202408:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/3/202408:20PRNUSInspira™ Announces Plans to Report the Primary Results for a..
27/2/202406:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/2/202406:02PRNUSInspira™ To Host Conference Call to Discuss Investor..
27/2/202406:00PRNUSInspira™ Announces Breakthrough Update: Nears First FDA..
22/2/202408:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/2/202406:00PRNUSInspira™ introduces high-end platform for bio-mimicking..
14/2/202408:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/2/202406:30PRNUSInspira™ Receives First Ever U.S. Patent Approval for an..
12/2/202415:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202415:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202408:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/2/202408:00PRNUSInspira™ Technologies Collaborates with a Leading Israeli..
30/1/202407:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202407:30PRNUSInspira™ Technologies Signs Strategic Agreement to Enter..
09/1/202408:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/1/202407:30PRNUSInspira™ Announces Plans to Launch and Target Single-Use..
02/1/202408:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/1/202407:30PRNUSInspira™ Technologies Signs Letter of Intent with..
28/12/202315:01PRNUSInspira™ Technologies Closes on $3.88 Million Registered..
28/12/202308:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/12/202315:46EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/12/202315:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/12/202313:16PRNUSInspira Announces $3.88 Million Registered Direct Offering
26/12/202307:45PRNUSInspira™ Announces 95% Accuracy Results for HYLA™ Blood..
18/12/202307:30PRNUSInspira Technologies to Participate in J.P. Morgan..
11/12/202308:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202308:00PRNUSIn Preparation for FDA Clearance and Device Deployment,..
29/11/202308:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202308:02PRNUSInspira Collaborates with Ennocure for development of a..
22/11/202315:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202308:40PRNUSInspira™ Technologies Reports Third Quarter 2023 Financial..
16/11/202308:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/11/202315:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202306:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202308:02PRNUSInspira™ Announces Israeli Innovation Authority Grant for..
25/10/202315:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
25/10/202307:30PRNUSInspira™ Granted U.S. Patent for INSPIRA™ ART500 Medical..
25/10/202306:48EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Su Consulta Reciente

NASDAQ
IINN
Inspira Technologies Oxy...
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados